Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients
PHASE3
To evaluate the clinical efficacy (median event-free survival) of APL-1202 ...
Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma
N/A
Upper urinary tract urothelial carcinoma (UTUC) accounts for 5%-10% of urot...
Status
Completed
Location
Ankara City Hospital Bilkent, Ankara, Ankara 06800
Start Date
2021-06-01
Trial ID
NCT06941038
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
NA
The objective of this prospective, single-center randomized controlled tria...